|Mutation Type||splice site (2 bp from exon)|
|Coordinate||15,702,157 bp (GRCm38)|
|Base Change||T ⇒ C (forward strand)|
|Gene Name||protein kinase, DNA activated, catalytic polypeptide|
|Synonym(s)||slip, DOXNPH, DNA-PKcs, XRCC7, dxnph, DNA-PK, DNAPDcs|
|Chromosomal Location||15,637,866-15,842,235 bp (+)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PHENOTYPE: Mutations at this locus effect genome stability, radiation sensitivity and DNA repair. Nonsense (scid) and null homozygotes have severe combined immunodeficiency. A BALB/c variant allele reduces enzyme activity and predisposes to breast cancer. [provided by MGI curators]
|Amino Acid Change|
|Institutional Source||Beutler Lab|
|Gene Model||not available|
|Predicted Effect||probably benign|
|Meta Mutation Damage Score||Not available|
|Is this an essential gene?||Probably essential (E-score: 0.956)|
|Candidate Explorer Status||CE: no linkage results|
Linkage Analysis Data
|Alleles Listed at MGI|
|Mode of Inheritance||Autosomal Recessive|
|Local Stock||Live Mice, Sperm|
|Last Updated||2019-07-17 4:33 PM by Diantha La Vine|
|Record Created||2011-02-08 5:40 PM by Carrie N. Arnold|
The clover mice exhibited a reduced T-independent IgM response to NP-Ficoll, and a null T-dependent IgG response to a vector based on Semliki Forest Virus encoding β-galactosidase (Figure 1). Peripheral lymphocyte frequencies have not been assessed.
|Nature of Mutation|
The clover mutation was mapped using bulk segregation analysis (BSA) of F2 backcross offspring using C57BL/10J as the mapping strain. The mutation showed strongest linkage with marker B10SNPS0225 at position 29856457 bp on Chromosome 16 (synthetic LOD = 3.6). Whole genome SOLiD sequencing of a homozygous clover mouse and validation by capillary sequencing identified a T to C transition at bp 15702250, 14.2 Mb from the marker of peak linkage, on chromosome 16 in the Genbank genomic region NC_000082. The effect of the mutation at the cDNA and protein level has not been tested.
The mutation is in intron 29, within the donor splice site, 2 nucleotides after exon 29. The mutated nucleotide is indicated in red; the splice donor sequence is shown in blue.
The 12,674 base pair Prkdc transcript encodes the 4,128 amino acid, 471 kDa catalytic subunit of the DNA-PK complex, DNA-PKCS (Figure 2 & 3). DNA-PKCS is a serine/threonine kinase and member of the phosphatidylinositol 3-kinase-like kinases (PIKK) family (see worker) [reviewed in (1)]. The PIKK family is similar to the PI3K family, with the exception that PIKK family members do not phosphorylate lipids [reviewed in (2)], but rather hundreds of proteins involved in the regulation of cell cycle progression, DNA repair, apoptosis, and cellular senescence (3). The PIKK family members ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related), along with DNA-PKCS, are involved in DNA repair [(4); reviewed in (5)]. In particular, DNA-PKCS is required for repair of DNA double strand breaks (DSB) during the process of nonhomologous end joining (NHEJ), and during the assembly of immune receptor genes in developing lymphocytes [V(D)J recombination]. Additional members of the PIKK family are SMG1 homolog (SMG1), mammalian target of rapamycin (mTOR), and transformation/transcription domain-associated protein (TRRAP), which are involved in nonsense-mediated decay of mRNA, regulation of nutrient-dependent signaling, and regulation of chromatin during transcription, respectively (3).
DNA-PKCS has several domains that are essential for its function (Figure 2 & 3). A leucine rich region (LRR, aa 1501-1536) mediates the association of DNA-PKCS with C1D, a DNA-binding nuclear matrix-associated factor that may be involved in gene regulation (1;6), and which is involved in NHEJ and homologous recombination in yeast (7). The LRR facilitates the intrinsic binding of DNA-PKCS to DNA (6), which occurs at low (nonphysiologic) salt concentrations and activates kinase activity (8); point mutations in the LRR reduce the ability of DNA-PKCS to rescue defective V(D)J recombination and radiosensitivity in DNA-PKCS-deficient cells (6). Association with C1D may contribute to the weak intrinsic DNA binding activity of DNA-PKCS. The DNA-PKCS protein also contains three tetratricopeptide repeats (TPR) (aa 1720-1753, 2921-2954, 2956-2983) that are proposed to assist in protein-protein interactions. TPR2 and TPR3 exist within a larger region that mediates binding of DNA-PKCS to the Ku heterodimer (Ku70 and Ku80), which is required to target DNA-PKCS to broken DNA ends in vivo. TPR1 forms part of a region shown to interact with Lyn tyrosine kinase (9).
A 380 amino acid region at the C terminus constitutes the catalytic domain, designated the PIKK domain, of DNA-PKCS (aa 3747-4015) (1;10). The PIKK domain is flanked by the FAT domain (named for its homology to FRAP, ATM and TRRAP, aa 2884-3539) and a FATC domain (FAT at the extreme C-terminus, aa 4096-4128) (10). The FAT and FATC domains occur in combination in all PIKK family members, suggesting a possible role in maintaining a structural conformation essential for the activation of the catalytic site (1;2). It has been shown the C-terminal region containing the FATC domain is essential for the kinase activity of DNA-PKCS (11-13). The N-terminal portion of the protein up to the FAT domain consists of HEAT (Huntingtin, Elongation factor 3, A subunit of protein phosphatase 2A and TOR1) repeats (14). HEAT repeats are helical structural repeats that mediate protein-protein interactions (15). In DNA-PKCS they are believed to contain recruitment sites for DNA repair proteins (16), and to hold the DNA in place while it is being repaired.
Autophosphorylation occurs on multiple sites across the length of DNA-PKCS and is essential for its function (16-19). Two major clusters of serine/threonine autophosphorylation sites near the center of the protein reciprocally regulate the activity of DNA-PKCS [(20-22); reviewed in (2;23)]. The ABCDE cluster contains six sites spanning resides 2609-2647 and their autophosphorylation is thought to induce a structural change in the protein that facilitates its release from the Ku dimer and the DNA as well as the inactivation of DNA-PKCS kinase activity (1;2;14;23). The result is DNA end processing by repair proteins that are presumably granted access to the broken DNA ends (20;21). The PQR cluster contains five sites spanning residues 2023-2056; phosphorylation of these sites inhibits DNA end processing (24). Site-directed mutational analysis demonstrated that phosphorylation of one or two sites within each cluster is functionally sufficient; only when all five or six sites were mutated was NHEJ impaired. Whether autophosphorylation of DNA-PKCS occurs in cis or in trans remains unknown (25;26); however, the interaction of two DNA-PKCS molecules on adjacent sides of a DSB to form a ‘synaptic complex’ is believed necessary prior to DNA end processing. DNA-PKCS also undergoes autophosphorylation within the kinase activation loop (22). Autophosphorylation of additional sites outside of the activation loop and ABCDE and PQR clusters may also be necessary for dissociation of DNA-PKCS from Ku and DNA ends (26).
DNA-PKCS has two caspase cleavage sites (Asp2712-Asn2713 and Asp2982-Gly2983) (27;28). Cleavage of the protein, which separates the FAT/PIKK/FATC module from the DNA-binding HEAT repeats and results in loss of DNA-PK activity, was observed following treatment of cultured cells with apoptotic agents. This mechanism may favor DNA fragmentation and nuclear disassembly necessary for apoptosis, and confine DNA-PK activity to viable cells.
Several cryo-electron microscopy studies (10;29-33), and recent solution and crystal structures obtained by X-ray scattering (34) and X-ray crystallography (PDB: 3KGV) [Figure 4 & 5; (14)] identified three major structural domains in DNA-PKcs termed the head, arms, and palm [reviewed in (35)] (Figure 3). The head structure, comprised of the PIKK domain and the FAT and FATC domains, resides on top of the ring-shaped palm region, which is composed of two arms that form a circular structure around a central opening that presumably holds the double stranded DNA. The arms consist of the N-terminal two-thirds of the protein and contain ~66 helices arranged as HEAT repeats in a ring structure; when viewed from the side this structure forms a concave shape. The N terminus of the protein lies in the right arm, while the LRR is in the left arm as shown in Figure 3. A gap at the bottom of the ring is predicted to widen upon autophosphorylation of either the ABCDE or PQR clusters, releasing the DNA after ligation. The cryo-EM studies also indicated the existence of additional openings not observed in the crystal structure, possibly between the head and palm regions, which were postulated to bind single stranded DNA.
The clover mutation affects the splice donor site within intron 29, and is predicted to cause skipping of exon 29. A transcript lacking exon 29 would encode the wild type sequence up to amino acid 1119, followed by four aberrant amino acids and a premature stop. This transcript would likely be subject to nonsense-mediated decay.
DNA-PKCS has been detected at mammalian telomeres in all cells (1;36). DNA-PK kinase activity appears to be cell cycle- and phosphorylation-dependent (e.g. it is reduced in S phase (compared to G1)) (37). DNA-PKCS has only been detected in higher eukaryotes (38). Interestingly, primate cells express 50 times more DNA-PK activity than rodent cells (23;39). Based on the interaction of DNA-PKCS with C1D, it has been suggested that DNA-PKCS may be sequestered in particular nuclear compartments (16).
DNA DSBs can occur as a result of exposure to external factors including ionizing radiation (IR) (e.g. medical x-rays and radon gas decay in the soil) (40), radiomimetic drugs (e.g. the antibiotic, bleomycin) (41), toxins (e.g. asbestos, silica, and titanium dioxide) (42), and topoisomerase inhibitors (e.g. camptothecin, which traps enzyme-DNA intermediates and inhibits the re-ligation of DNA) (43). Cellular processes such as the generation of reactive oxygen species as a byproduct of oxidative metabolism, the collapse of DNA replication forks (upon recognition of single-stranded breaks by the replication machinery) (44), and, in the case of B and T lymphocytes, immune receptor gene arrangement, also cause DSBs (16;38;45;46). Repair of DSBs is required to prevent chromosomal abnormalities and chromosome loss, and thereby maintain genomic stability. If left unrepaired, cell cycle arrest typically occurs, leading to cell death (45;47;48). In addition, instances of cancer can occur after a tumor suppressor gene is inactivated or deleted by a DSB, or when an oncogene is activated or translocated (49;50).
DSB repair pathways
There are three DNA DSB repair pathways: single-strand annealing (SSA), homologous recombination (HR), and nonhomologous end-joining (NHEJ) (51). In SSA, which requires homologous sequences to flank the break site, the nonhomologous DNA ends are removed, leaving overhangs that are aligned and annealed (45). After annealing, DNA synthesis and ligation occur. SSA results in deletion of the region between homologous sequences. In contrast, HR is a relatively error-free mechanism for DSB repair that relies on the homologous region on the sister chromatid as a template for DNA synthesis (Figure 6A) (1;16). HR is limited to replicating cells (including early embryonic developmental stages) and can be observed only after DNA replication in the S and G2 phases (52) . Finally, NHEJ is a rapid repair mechanism that simply ligates broken DNA ends after minimal or no processing (Figure 6B). NHEJ occurs in all phases of the cell cycle and is thought to be the primary DNA repair pathway in mammalian cells (53;54). NHEJ is prone to generating mutations at the point of ligation, and may result in inversions or translocations if the joined strands were not originally contiguous.
Nonhomologous end-joining (NHEJ)
Seven factors are necessary for NHEJ: Ku70, Ku80, DNA-PKCS, XRCC4 (X-ray repair cross-complementing 4), DNA ligase IV, Artemis, and XLF (XRCC4-like factor; also known as Cernunnos) (1;16;55). During a DSB repair, the break is recognized by the Ku heterodimer composed of Ku70 and Ku80, which encircles the DNA and cups the DNA termini into an accessible binding pocket (56). The Ku dimer can recognize blunt ends, hairpin ends, and 5’ or 3’ overhangs; two in vitro studies using purified oligonucleotides containing hairpin ends found that the Ku heterodimer (and DNA-PKCS) can bind hairpin ends but the kinase could not be activated (48;57). The Ku heterodimer recruits and activates DNA-PKCS, forming the Ku/DNA-PKCS complex known as DNA-PK. The Ku/DNA-PKCS interaction not only assists in localizing the complex to the DNA ends, it also protects DNA ends from nuclease digestion prior to re-ligation (45;58). Following recruitment of DNA-PKCS to the Ku-DNA complex, Ku translocates inward ~10 bp from the DNA ends, allowing DNA-PKCS to bind to the DNA termini (38). Two adjacent DNA-PKCS molecules interact across the DSB, holding the DNA ends in close proximity within a synaptic complex. Crystallographic studies have shown that the synaptic complex in NHEJ consists of two DNA ends, two Ku heterodimers, and two DNA-PKCS proteins (33;58). The formation of a synaptic complex is essential for the activation of DNA-PKCS (58).
Nucleases (e.g. 5’: FEN1, EXO1, and Sep1 (59-61); 3’: MRE11 (62)) and polymerases (e.g. polβ, polε, and polδ) are often required to remove several nucleotides or to fill in gaps of several nucleotides, respectively, to facilitate the proper conformation for ligation (53). The colocalization of DNA polymerase X family members (e.g. terminal deoxynucleotidyl transferase (TdT), pol μ, pol λ, and polβ) with DNA-PKCS as well as the interactions of DNA pol X with both Ku and the DNA ligase IV-XRCC4 complex suggest that the DNA polymerase X family participates in the filling in of short gaps prior to re-ligation (1;23). To protect the DNA termini of a DSB from degradation or premature and incorrect ligation, DNA-PKCS is positioned as a “cap” on the DNA ends (18;63). Before re-ligation of the DNA ends and finalization of the DSB repair, the DNA-PKCS cap must be removed or altered. Autophosphorylation of DNA-PKCS results in release of the cap and accessibility of the termini to enzymes and ligases needed to complete the repair (e.g. Artemis, DNA polymerase X family members and the DNA ligase IV-XRCC4 dimer) (1;16;58). Artemis and DNA-PKCS form a complex with endonuclease activity that cleaves 5’ and 3’ overhangs during NHEJ, and opens hairpins generated by the RAG complex during V(D)J recombination [(64); reviewed in (16)]. In order to activate its nuclease activity, Artemis is phosphorylated by DNA-PKCS (65). The DNA ligase IV-XRCC4 dimer rejoins the DNA ends, with XRCC4 both interacting with and catalytically stimulating DNA ligase IV (16). XLF functions to stimulate the ability of XRCC4-DNA ligase IV to ligate in the presence of Mg2+ (66).
In general, mutations in genes required for DNA damage repair can lead to radiosensitivity, immunodeficiency, cancer predisposition, and premature aging (38). More specifically, mutations in components of the DSB repair pathway cause a number of conditions including: LIG4 syndrome, radiosensitive severe combined immunodeficiency (RS-SCID), ataxia-telangiectasia (AT), AT-like disorder (ATLD), and Nijmegen breakage syndrome (NBS) (38). In LIG4 syndrome (OMIM #606593), there are developmental defects and growth retardation, immunodeficiency, and a predisposition to cancer due to mutations in Ligase IV (67-69). SCID (OMIM #602450) can be caused by a mutation in the gene encoding Artemis [DCLRE1C, (70)] as well as mutations in the genes encoding DNA-PKCS [PRKDC, (71)], and DNA ligase IV [LIG4, (72)]; mutations in recombination-activating gene 1 [RAG1] (Rag1, see maladaptive and huckle) and RAG2 lead to B cell-negative SCID (see OMIM #601457 for more details) (73). RS-SCID patients suffer from immunodeficiency and have a predisposition to cancer. In AT (OMIM #208900) and ATLD (OMIM #604391), patients have cerebellar ataxia and immunodeficiency as well as a predisposition to cancer due to mutations in the ATM and MRE11A genes, respectively (74;75). NBS (OMIM #251260) is due to a mutation in the gene encoding NBS1, another protein essential for DNA damage detection and response. NBS patients suffer from cancer predisposition as well as mental and growth retardation (76;77). Interestingly, cells deficient in DNA-PKCS or Artemis are sensitive to ionizing radiation, but do not have cellular growth defects (65).
DNA-PKCS was initially identified in HeLa cell extracts as a kinase activated by double stranded DNA and was subsequently designated a member of the PIKK family (78;79). DNA-PKCS activity is regulated by several different factors (Table 1).
Table 1: Regulation of DNA-PK (adapted from (45))
In addition to its role in NHEJ (described above), DNA-PK functions in a variety of cellular processes that involve DNA regulation:
There are several Prkdc-deficient model systems that have been characterized. For example, in DNA-PKCS-deficient cell lines, transfection of DNA-PKCS constructs with mutations within the kinase domain were unable to participate in NHEJ and V(D)J recombination (16). In addition, there are several animal models of SCID (e.g. mouse (120), Arabian horses (121), and Jack Russell terriers (122)) with mutations in Prkdc (123). Animals with SCID present with several features including: lymphopenia, hypogammaglobulinemia, premature aging (e.g. shortened telomeres), a large number of telomeric fusions, and impaired T and B cell-mediated functions (e.g. defective V(D)J recombination and reduced numbers of peripheral lymphocytes) (45;65;123). Mutations in Prkdc also lead to hypersensitivity to IR and radiomimetic chemicals (124). In horses with mutations in DNA-PKCS, decreased numbers of B and T lymphocytes were documented, although natural killer cell activity was normal (125). The decreased T and B cell functions were due to an inability of the lymphocytes to properly mature due to defective V(D)J recombination. In a spontaneous mouse model of SCID, a DNA-PKCS point mutation resulting in the loss of 83 C-terminal amino acids, a reduction in protein expression, and a block in lymphocyte development has been identified (126). Although a variety of mutations in Prkdc cause SCID in the aforementioned animal models, only one case of human SCID has been attributed to mutation of PRKDC (127). In that patient, two homozygous changes were verified: deletion of a glycine at 2113 and a missense mutation (L3062R) that was shown to be the disease-causing mutation . It was speculated that due to the differences in expression levels across species, a deficiency of DNA-PKCS in humans is incompatible with life (23).
The clover mutation causes a similar phenotype to other Prkdc mutations: decreased T and B cell function likely due to a disruption in V(D)J recombination (Figure 8).
|Primers||Primers cannot be located by automatic search.|
Clover genotyping is performed by amplifying the region containing the mutation using PCR followed by sequencing of the amplified region to detect the nucleotide change. The following primers were used for PCR amplification:
Primers for PCR amplification
Clover (F): 5'- TGAGGCTGTTGGTCATGGACTTTCTA -3'
Clover (R): 5'- TGTGACACTCAGTCCTTATACTGCAAAATT -3'
Primers for Sequencing
Clover_seq (F): 5'- CCAGCATGGTGGCTCTAAATC -3'
Clover_seq (R): 5'- CATCTTCAGCATTCATCAGATGGA -3'
1) 94° C 2:00
2) 94° C 0:30
3) 57° C 0:30
4) 72° C 1:00
5) repeat steps (2-4) 29x
6) 72° C 7:00
7) 4° C ∞
The following sequence of 1698 nucleotides (from Genbank genomic region: NC_000082 of the linear genomic sequence of Prkdc) is amplified:
63301 tgaggctg ttggtcatgg
63361 actttctatt tggatgtgat actccttttg ggtgtatgta tataatagat atgtgttgca
63421 gtaggcaatt aacctacact caaatcgccc tgacgtggca atgagagttc cttgctaccc
63481 acctcaatgt tctggattcc cgaatgaaag acacacacac agccctgtat ttaatatgcc
63541 ttaatcagct caatggttgg gccactacca aacctccacg tggctaacac ctcccttctg
63601 atactcctga attattactt actaaaatct atattccatc tttgttgccc tagacccagt
63661 ggggtctctg gctcccgatt gctgtgcatt cttttctgca cctctcatat ctggacctta
63721 ttgctttccc agcatggtgg ctctaaatca tgcttcctct cttggccccc ttgcccgtga
63781 atcttcgagt tccacctttg tctccctgcc agccattggc cgccaacaac tttattgact
63841 aatcagaacc aactgggggc aggaaccctc agcatctcac atatggattc tagaggaatt
63901 ttgggaaccc agttaacatc atacaagcat tagaccaaat tcaaattcaa attcacaaca
63961 tacatgcatg ttgtcatgcc ttctttcagt catgagtttg ggtttagttt aggatttgaa
64021 atgtaagtca tttattttaa tttcatattt tgagatgtag aaatactaaa tctatagtaa
64081 aattaccttg gtattcacaa aattcggtca gcagatttat aatattactg tgttaatgac
64141 aatctgattt gttttctatg atatatttct gtactggcca cacattcagg cacagttcag
64201 cagtgctgtg atgccatcga tcacctaaga cgcatcattg aaaagaagca tgtctcttta
64261 aacaaagcaa aaaagcgacg tttgccacag taggtgatac tgtttttctt cttttcttta
64321 acccaacaca aagctaattt ccatctgatg aatgctgaag atgaatatgt agaatataaa
64381 gaattatctt tgtaaggaag aaatgtgtag aagggtggta tgagttttct tttctttttt
64441 tttttcattt tttaaaatta gatactttat ttacagttca aattttatcc ccttccctcg
64501 tttccactcc aaaaaccctc ctatcccatc ccccctgccc cctgctcact aacccaccca
64561 ctctcgtttc cctgtcctgg cattcctcta cactggggca tcgagccttc acaaggccaa
64621 gggcctctcc tctcattgat gtcccacgag gccatcctct gctacatatg cagctgaagc
64681 cttgagtccc tccttgtgta ctctttggtt ggtggtttag ttcctgggag atcagggggt
64741 actggttggt tcatattgtt gttcctccta tggggctgca aaccccttca gctccttggg
64801 ttctttctct agctttattg gggagcagtc atttttctag caaaatttaa aacttttaag
64861 tttgaaagta catggtttca ggatgataat atttgattat ggtttggata ggtatccata
64921 ttgacagtaa gttttgaaca ttgtatttta cctgttacaa gttttgtaag tcattattta
64981 attagaatat ttatgaactg ttacacaata aattttgcag tataaggact gagtgtcaca
PCR primer binding sites are underlined; Sequencing primer binding sites are highlighted; the mutated T is highlighted in red.
1. Dip, R., and Naegeli, H. (2005) More than just Strand Breaks: The Recognition of Structural DNA Discontinuities by DNA-Dependent Protein Kinase Catalytic Subunit. FASEB J.. 19, 704-715.
2. Hill, R., and Lee, P. W. (2010) The DNA-Dependent Protein Kinase (DNA-PK): More than just a Case of Making Ends Meet? Cell. Cycle. 9, 3460-3469.
3. Lovejoy, C. A., and Cortez, D. (2009) Common Mechanisms of PIKK Regulation. DNA Repair (Amst). 8, 1004-1008.
4. Falck, J., Coates, J., and Jackson, S. P. (2005) Conserved Modes of Recruitment of ATM, ATR and DNA-PKcs to Sites of DNA Damage. Nature. 434, 605-611.
5. Abraham, R. T. (2001) Cell Cycle Checkpoint Signaling through the ATM and ATR Kinases. Genes Dev.. 15, 2177-2196.
6. Gupta, S., and Meek, K. (2005) The Leucine Rich Region of DNA-PKcs Contributes to its Innate DNA Affinity. Nucleic Acids Res.. 33, 6972-6981.
7. Erdemir, T., Bilican, B., Cagatay, T., Goding, C. R., and Yavuzer, U. (2002) Saccharomyces Cerevisiae C1D is Implicated in both Non-Homologous DNA End Joining and Homologous Recombination. Mol. Microbiol.. 46, 947-957.
8. Hammarsten, O., and Chu, G. (1998) DNA-Dependent Protein Kinase: DNA Binding and Activation in the Absence of Ku. Proc. Natl. Acad. Sci. U. S. A.. 95, 525-530.
9. Kumar, S., Pandey, P., Bharti, A., Jin, S., Weichselbaum, R., Weaver, D., Kufe, D., and Kharbanda, S. (1998) Regulation of DNA-Dependent Protein Kinase by the Lyn Tyrosine Kinase. J. Biol. Chem.. 273, 25654-25658.
10. Rivera-Calzada, A., Maman, J. D., Spagnolo, L., Pearl, L. H., and Llorca, O. (2005) Three-Dimensional Structure and Regulation of the DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs). Structure. 13, 243-255.
11. Jiang, X., Sun, Y., Chen, S., Roy, K., and Price, B. D. (2006) The FATC Domains of PIKK Proteins are Functionally Equivalent and Participate in the Tip60-Dependent Activation of DNA-PKcs and ATM. J. Biol. Chem.. 281, 15741-15746.
12. Beamish, H. J., Jessberger, R., Riballo, E., Priestley, A., Blunt, T., Kysela, B., and Jeggo, P. A. (2000) The C-Terminal Conserved Domain of DNA-PKcs, Missing in the SCID Mouse, is Required for Kinase Activity. Nucleic Acids Res.. 28, 1506-1513.
13. Priestley, A., Beamish, H. J., Gell, D., Amatucci, A. G., Muhlmann-Diaz, M. C., Singleton, B. K., Smith, G. C., Blunt, T., Schalkwyk, L. C., Bedford, J. S., Jackson, S. P., Jeggo, P. A., and Taccioli, G. E. (1998) Molecular and Biochemical Characterisation of DNA-Dependent Protein Kinase-Defective Rodent Mutant Irs-20. Nucleic Acids Res.. 26, 1965-1973.
14. Sibanda, B. L., Chirgadze, D. Y., and Blundell, T. L. (2010) Crystal Structure of DNA-PKcs Reveals a Large Open-Ring Cradle Comprised of HEAT Repeats. Nature. 463, 118-121.
15. Andrade, M. A., Perez-Iratxeta, C., and Ponting, C. P. (2001) Protein Repeats: Structures, Functions, and Evolution. J. Struct. Biol.. 134, 117-131.
16. Meek, K., Gupta, S., Ramsden, D. A., and Lees-Miller, S. P. (2004) The DNA-Dependent Protein Kinase: The Director at the End. Immunol. Rev.. 200, 132-141.
17. Uematsu, N., Weterings, E., Yano, K., Morotomi-Yano, K., Jakob, B., Taucher-Scholz, G., Mari, P. O., van Gent, D. C., Chen, B. P., and Chen, D. J. (2007) Autophosphorylation of DNA-PKCS Regulates its Dynamics at DNA Double-Strand Breaks. J. Cell Biol.. 177, 219-229.
18. Block, W. D., Yu, Y., Merkle, D., Gifford, J. L., Ding, Q., Meek, K., and Lees-Miller, S. P. (2004) Autophosphorylation-Dependent Remodeling of the DNA-Dependent Protein Kinase Catalytic Subunit Regulates Ligation of DNA Ends. Nucleic Acids Res.. 32, 4351-4357.
19. Reddy, Y. V., Ding, Q., Lees-Miller, S. P., Meek, K., and Ramsden, D. A. (2004) Non-Homologous End Joining Requires that the DNA-PK Complex Undergo an Autophosphorylation-Dependent Rearrangement at DNA Ends. J. Biol. Chem.. 279, 39408-39413.
20. Ding, Q., Reddy, Y. V., Wang, W., Woods, T., Douglas, P., Ramsden, D. A., Lees-Miller, S. P., and Meek, K. (2003) Autophosphorylation of the Catalytic Subunit of the DNA-Dependent Protein Kinase is Required for Efficient End Processing during DNA Double-Strand Break Repair. Mol. Cell. Biol.. 23, 5836-5848.
21. Chan, D. W., Chen, B. P., Prithivirajsingh, S., Kurimasa, A., Story, M. D., Qin, J., and Chen, D. J. (2002) Autophosphorylation of the DNA-Dependent Protein Kinase Catalytic Subunit is Required for Rejoining of DNA Double-Strand Breaks. Genes Dev.. 16, 2333-2338.
22. Douglas, P., Cui, X., Block, W. D., Yu, Y., Gupta, S., Ding, Q., Ye, R., Morrice, N., Lees-Miller, S. P., and Meek, K. (2007) The DNA-Dependent Protein Kinase Catalytic Subunit is Phosphorylated in Vivo on Threonine 3950, a Highly Conserved Amino Acid in the Protein Kinase Domain. Mol. Cell. Biol.. 27, 1581-1591.
23. Meek, K., Dang, V., and Lees-Miller, S. P. (2008) DNA-PK: The Means to Justify the Ends? Adv. Immunol.. 99, 33-58.
24. Cui, X., Yu, Y., Gupta, S., Cho, Y. M., Lees-Miller, S. P., and Meek, K. (2005) Autophosphorylation of DNA-Dependent Protein Kinase Regulates DNA End Processing and may also Alter Double-Strand Break Repair Pathway Choice. Mol. Cell. Biol.. 25, 10842-10852.
25. Jovanovic, M., and Dynan, W. S. (2006) Terminal DNA Structure and ATP Influence Binding Parameters of the DNA-Dependent Protein Kinase at an Early Step Prior to DNA Synapsis. Nucleic Acids Res.. 34, 1112-1120.
26. Meek, K., Douglas, P., Cui, X., Ding, Q., and Lees-Miller, S. P. (2007) Trans Autophosphorylation at DNA-Dependent Protein Kinase's Two Major Autophosphorylation Site Clusters Facilitates End Processing but Not End Joining. Mol. Cell. Biol.. 27, 3881-3890.
27. Casciola-Rosen, L. A., Anhalt, G. J., and Rosen, A. (1995) DNA-Dependent Protein Kinase is One of a Subset of Autoantigens Specifically Cleaved Early during Apoptosis. J. Exp. Med.. 182, 1625-1634.
28. Song, Q., Lees-Miller, S. P., Kumar, S., Zhang, Z., Chan, D. W., Smith, G. C., Jackson, S. P., Alnemri, E. S., Litwack, G., Khanna, K. K., and Lavin, M. F. (1996) DNA-Dependent Protein Kinase Catalytic Subunit: A Target for an ICE-Like Protease in Apoptosis. EMBO J.. 15, 3238-3246.
29. Chiu, C. Y., Cary, R. B., Chen, D. J., Peterson, S. R., and Stewart, P. L. (1998) Cryo-EM Imaging of the Catalytic Subunit of the DNA-Dependent Protein Kinase. J. Mol. Biol.. 284, 1075-1081.
30. Leuther, K. K., Hammarsten, O., Kornberg, R. D., and Chu, G. (1999) Structure of DNA-Dependent Protein Kinase: Implications for its Regulation by DNA. EMBO J.. 18, 1114-1123.
31. Williams, D. R., Lee, K. J., Shi, J., Chen, D. J., and Stewart, P. L. (2008) Cryo-EM Structure of the DNA-Dependent Protein Kinase Catalytic Subunit at Subnanometer Resolution Reveals Alpha Helices and Insight into DNA Binding. Structure. 16, 468-477.
32. Boskovic, J., Rivera-Calzada, A., Maman, J. D., Chacon, P., Willison, K. R., Pearl, L. H., and Llorca, O. (2003) Visualization of DNA-Induced Conformational Changes in the DNA Repair Kinase DNA-PKcs. EMBO J.. 22, 5875-5882.
33. Spagnolo, L., Rivera-Calzada, A., Pearl, L. H., and Llorca, O. (2006) Three-Dimensional Structure of the Human DNA-PKcs/Ku70/Ku80 Complex Assembled on DNA and its Implications for DNA DSB Repair. Mol. Cell. 22, 511-519.
34. Hammel, M., Yu, Y., Mahaney, B. L., Cai, B., Ye, R., Phipps, B. M., Rambo, R. P., Hura, G. L., Pelikan, M., So, S., Abolfath, R. M., Chen, D. J., Lees-Miller, S. P., and Tainer, J. A. (2010) Ku and DNA-Dependent Protein Kinase Dynamic Conformations and Assembly Regulate DNA Binding and the Initial Non-Homologous End Joining Complex. J. Biol. Chem.. 285, 1414-1423.
35. Dobbs, T. A., Tainer, J. A., and Lees-Miller, S. P. (2010) A Structural Model for Regulation of NHEJ by DNA-PKcs Autophosphorylation. DNA Repair (Amst). 9, 1307-1314.
36. d'Adda di Fagagna, F., Hande, M. P., Tong, W. M., Roth, D., Lansdorp, P. M., Wang, Z. Q., and Jackson, S. P. (2001) Effects of DNA Nonhomologous End-Joining Factors on Telomere Length and Chromosomal Stability in Mammalian Cells. Curr. Biol.. 11, 1192-1196.
37. Chen, B. P., Chan, D. W., Kobayashi, J., Burma, S., Asaithamby, A., Morotomi-Yano, K., Botvinick, E., Qin, J., and Chen, D. J. (2005) Cell Cycle Dependence of DNA-Dependent Protein Kinase Phosphorylation in Response to DNA Double Strand Breaks. J. Biol. Chem.. 280, 14709-14715.
38. Cahill, D., Connor, B., and Carney, J. P. (2006) Mechanisms of Eukaryotic DNA Double Strand Break Repair. Front. Biosci.. 11, 1958-1976.
39. Finnie, N. J., Gottlieb, T. M., Blunt, T., Jeggo, P. A., and Jackson, S. P. (1995) DNA-Dependent Protein Kinase Activity is Absent in Xrs-6 Cells: Implications for Site-Specific Recombination and DNA Double-Strand Break Repair. Proc. Natl. Acad. Sci. U. S. A.. 92, 320-324.
40. Mitra, A. K., Bhat, N., Sarma, A., and Krishna, M. (2005) Alteration in the Expression of Signaling Parameters Following Carbon Ion Irradiation. Mol. Cell. Biochem.. 276, 169-173.
41. Martensson, S., Nygren, J., Osheroff, N., and Hammarsten, O. (2003) Activation of the DNA-Dependent Protein Kinase by Drug-Induced and Radiation-Induced DNA Strand Breaks. Radiat. Res.. 160, 291-301.
42. Msiska, Z., Pacurari, M., Mishra, A., Leonard, S. S., Castranova, V., and Vallyathan, V. (2010) DNA Double-Strand Breaks by Asbestos, Silica, and Titanium Dioxide: Possible Biomarker of Carcinogenic Potential? Am. J. Respir. Cell Mol. Biol.. 43, 210-219.
43. Shao, R. G., Cao, C. X., Zhang, H., Kohn, K. W., Wold, M. S., and Pommier, Y. (1999) Replication-Mediated DNA Damage by Camptothecin Induces Phosphorylation of RPA by DNA-Dependent Protein Kinase and Dissociates RPA:DNA-PK Complexes. EMBO J.. 18, 1397-1406.
44. Saleh-Gohari, N., Bryant, H. E., Schultz, N., Parker, K. M., Cassel, T. N., and Helleday, T. (2005) Spontaneous Homologous Recombination is Induced by Collapsed Replication Forks that are Caused by Endogenous DNA Single-Strand Breaks. Mol. Cell. Biol.. 25, 7158-7169.
45. Collis, S. J., DeWeese, T. L., Jeggo, P. A., and Parker, A. R. (2005) The Life and Death of DNA-PK. Oncogene. 24, 949-961.
46. Shrivastav, M., De Haro, L. P., and Nickoloff, J. A. (2008) Regulation of DNA Double-Strand Break Repair Pathway Choice. Cell Res.. 18, 134-147.
47. Kaina, B. (2003) DNA Damage-Triggered Apoptosis: Critical Role of DNA Repair, Double-Strand Breaks, Cell Proliferation and Signaling. Biochem. Pharmacol.. 66, 1547-1554.
48. Hammarsten, O., DeFazio, L. G., and Chu, G. (2000) Activation of DNA-Dependent Protein Kinase by Single-Stranded DNA Ends. J. Biol. Chem.. 275, 1541-1550.
49. Elliott, B., and Jasin, M. (2002) Double-Strand Breaks and Translocations in Cancer. Cell Mol. Life Sci.. 59, 373-385.
50. Khanna, K. K., and Jackson, S. P. (2001) DNA Double-Strand Breaks: Signaling, Repair and the Cancer Connection. Nat. Genet.. 27, 247-254.
51. Frankenberg-Schwager, M., Gebauer, A., Koppe, C., Wolf, H., Pralle, E., and Frankenberg, D. (2009) Single-Strand Annealing, Conservative Homologous Recombination, Nonhomologous DNA End Joining, and the Cell Cycle-Dependent Repair of DNA Double-Strand Breaks Induced by Sparsely Or Densely Ionizing Radiation. Radiat. Res.. 171, 265-273.
52. Rothkamm, K., Kruger, I., Thompson, L. H., and Lobrich, M. (2003) Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle. Mol. Cell. Biol.. 23, 5706-5715.
53. Lieber, M. R. (1999) The Biochemistry and Biological Significance of Nonhomologous DNA End Joining: An Essential Repair Process in Multicellular Eukaryotes. Genes Cells. 4, 77-85.
54. Lieber, M. R. (2008) The Mechanism of Human Nonhomologous DNA End Joining. J. Biol. Chem.. 283, 1-5.
55. Ahnesorg, P., Smith, P., and Jackson, S. P. (2006) XLF Interacts with the XRCC4-DNA Ligase IV Complex to Promote DNA Nonhomologous End-Joining. Cell. 124, 301-313.
56. Walker, J. R., Corpina, R. A., and Goldberg, J. (2001) Structure of the Ku Heterodimer Bound to DNA and its Implications for Double-Strand Break Repair. Nature. 412, 607-614.
57. Smider, V., Rathmell, W. K., Brown, G., Lewis, S., and Chu, G. (1998) Failure of Hairpin-Ended and Nicked DNA to Activate DNA-Dependent Protein Kinase: Implications for V(D)J Recombination. Mol. Cell. Biol.. 18, 6853-6858.
58. Weterings, E., and Chen, D. J. (2007) DNA-Dependent Protein Kinase in Nonhomologous End Joining: A Lock with Multiple Keys? J. Cell Biol.. 179, 183-186.
59. Fiorentini, P., Huang, K. N., Tishkoff, D. X., Kolodner, R. D., and Symington, L. S. (1997) Exonuclease I of Saccharomyces Cerevisiae Functions in Mitotic Recombination in Vivo and in Vitro. Mol. Cell. Biol.. 17, 2764-2773.
60. Lieber, M. R. (1997) The FEN-1 Family of Structure-Specific Nucleases in Eukaryotic DNA Replication, Recombination and Repair. Bioessays. 19, 233-240.
61. Johnson, A. W., and Kolodner, R. D. (1991) Strand Exchange Protein 1 from Saccharomyces Cerevisiae. A Novel Multifunctional Protein that Contains DNA Strand Exchange and Exonuclease Activities. J. Biol. Chem.. 266, 14046-14054.
62. Paull, T. T., and Gellert, M. (1998) The 3' to 5' Exonuclease Activity of Mre 11 Facilitates Repair of DNA Double-Strand Breaks. Mol. Cell. 1, 969-979.
63. Weterings, E., Verkaik, N. S., Bruggenwirth, H. T., Hoeijmakers, J. H., and van Gent, D. C. (2003) The Role of DNA Dependent Protein Kinase in Synapsis of DNA Ends. Nucleic Acids Res.. 31, 7238-7246.
64. Ma, Y., Pannicke, U., Schwarz, K., and Lieber, M. R. (2002) Hairpin Opening and Overhang Processing by an Artemis/DNA-Dependent Protein Kinase Complex in Nonhomologous End Joining and V(D)J Recombination. Cell. 108, 781-794.
65. Jolly, C. J., Cook, A. J., and Manis, J. P. (2008) Fixing DNA Breaks during Class Switch Recombination. J. Exp. Med.. 205, 509-513.
66. Gu, J., Lu, H., Tsai, A. G., Schwarz, K., and Lieber, M. R. (2007) Single-Stranded DNA Ligation and XLF-Stimulated Incompatible DNA End Ligation by the XRCC4-DNA Ligase IV Complex: Influence of Terminal DNA Sequence. Nucleic Acids Res.. 35, 5755-5762.
67. O'Driscoll, M., Cerosaletti, K. M., Girard, P. M., Dai, Y., Stumm, M., Kysela, B., Hirsch, B., Gennery, A., Palmer, S. E., Seidel, J., Gatti, R. A., Varon, R., Oettinger, M. A., Neitzel, H., Jeggo, P. A., and Concannon, P. (2001) DNA Ligase IV Mutations Identified in Patients Exhibiting Developmental Delay and Immunodeficiency. Mol. Cell. 8, 1175-1185.
68. Girard, P. M., Kysela, B., Harer, C. J., Doherty, A. J., and Jeggo, P. A. (2004) Analysis of DNA Ligase IV Mutations found in LIG4 Syndrome Patients: The Impact of Two Linked Polymorphisms. Hum. Mol. Genet.. 13, 2369-2376.
69. Ben-Omran, T. I., Cerosaletti, K., Concannon, P., Weitzman, S., and Nezarati, M. M. (2005) A Patient with Mutations in DNA Ligase IV: Clinical Features and Overlap with Nijmegen Breakage Syndrome. Am. J. Med. Genet. A.. 137A, 283-287.
70. Moshous, D., Callebaut, I., de Chasseval, R., Corneo, B., Cavazzana-Calvo, M., Le Deist, F., Tezcan, I., Sanal, O., Bertrand, Y., Philippe, N., Fischer, A., and de Villartay, J. P. (2001) Artemis, a Novel DNA Double-Strand Break repair/V(D)J Recombination Protein, is Mutated in Human Severe Combined Immune Deficiency. Cell. 105, 177-186.
71. Bosma, G. C., Custer, R. P., and Bosma, M. J. (1983) A Severe Combined Immunodeficiency Mutation in the Mouse. Nature. 301, 527-530.
72. van der Burg, M., van Veelen, L. R., Verkaik, N. S., Wiegant, W. W., Hartwig, N. G., Barendregt, B. H., Brugmans, L., Raams, A., Jaspers, N. G., Zdzienicka, M. Z., van Dongen, J. J., and van Gent, D. C. (2006) A New Type of Radiosensitive T-B-NK+ Severe Combined Immunodeficiency Caused by a LIG4 Mutation. J. Clin. Invest.. 116, 137-145.
73. Schwarz, K., Gauss, G. H., Ludwig, L., Pannicke, U., Li, Z., Lindner, D., Friedrich, W., Seger, R. A., Hansen-Hagge, T. E., Desiderio, S., Lieber, M. R., and Bartram, C. R. (1996) RAG Mutations in Human B Cell-Negative SCID. Science. 274, 97-99.
74. Jaspers, N. G., Painter, R. B., Paterson, M. C., Kidson, C., and Inoue, T. (1985) Complementation Analysis of Ataxia-Telangiectasia. Kroc Found. Ser.. 19, 147-162.
75. Hernandez, D., McConville, C. M., Stacey, M., Woods, C. G., Brown, M. M., Shutt, P., Rysiecki, G., and Taylor, A. M. (1993) A Family Showing no Evidence of Linkage between the Ataxia Telangiectasia Gene and Chromosome 11q22-23. J. Med. Genet.. 30, 135-140.
76. Weemaes, C. M., Hustinx, T. W., Scheres, J. M., van Munster, P. J., Bakkeren, J. A., and Taalman, R. D. (1981) A New Chromosomal Instability Disorder: The Nijmegen Breakage Syndrome. Acta Paediatr. Scand.. 70, 557-564.
77. Chrzanowska, K. H., Kleijer, W. J., Krajewska-Walasek, M., Bialecka, M., Gutkowska, A., Goryluk-Kozakiewicz, B., Michalkiewicz, J., Stachowski, J., Gregorek, H., and Lyson-Wojciechowska, G. (1995) Eleven Polish Patients with Microcephaly, Immunodeficiency, and Chromosomal Instability: The Nijmegen Breakage Syndrome. Am. J. Med. Genet.. 57, 462-471.
78. Lees-Miller, S. P., Chen, Y. R., and Anderson, C. W. (1990) Human Cells Contain a DNA-Activated Protein Kinase that Phosphorylates Simian Virus 40 T Antigen, Mouse p53, and the Human Ku Autoantigen. Mol. Cell. Biol.. 10, 6472-6481.
79. Carter, T., Vancurova, I., Sun, I., Lou, W., and DeLeon, S. (1990) A DNA-Activated Protein Kinase from HeLa Cell Nuclei. Mol. Cell. Biol.. 10, 6460-6471.
80. Yavuzer, U., Smith, G. C., Bliss, T., Werner, D., and Jackson, S. P. (1998) DNA End-Independent Activation of DNA-PK Mediated Via Association with the DNA-Binding Protein C1D. Genes Dev.. 12, 2188-2199.
81. Jin, S., Kharbanda, S., Mayer, B., Kufe, D., and Weaver, D. T. (1997) Binding of Ku and c-Abl at the Kinase Homology Region of DNA-Dependent Protein Kinase Catalytic Subunit. J. Biol. Chem.. 272, 24763-24766.
82. Kharbanda, S., Pandey, P., Jin, S., Inoue, S., Bharti, A., Yuan, Z. M., Weichselbaum, R., Weaver, D., and Kufe, D. (1997) Functional Interaction between DNA-PK and c-Abl in Response to DNA Damage. Nature. 386, 732-735.
83. Han, Z., Malik, N., Carter, T., Reeves, W. H., Wyche, J. H., and Hendrickson, E. A. (1996) DNA-Dependent Protein Kinase is a Target for a CPP32-Like Apoptotic Protease. J. Biol. Chem.. 271, 25035-25040.
84. Goudelock, D. M., Jiang, K., Pereira, E., Russell, B., and Sanchez, Y. (2003) Regulatory Interactions between the Checkpoint Kinase Chk1 and the Proteins of the DNA-Dependent Protein Kinase Complex. J. Biol. Chem.. 278, 29940-29947.
85. Nueda, A., Hudson, F., Mivechi, N. F., and Dynan, W. S. (1999) DNA-Dependent Protein Kinase Protects Against Heat-Induced Apoptosis. J. Biol. Chem.. 274, 14988-14996.
86. Huang, J., Nueda, A., Yoo, S., and Dynan, W. S. (1997) Heat Shock Transcription Factor 1 Binds Selectively in Vitro to Ku Protein and the Catalytic Subunit of the DNA-Dependent Protein Kinase. J. Biol. Chem.. 272, 26009-26016.
87. Peterson, S. R., Jesch, S. A., Chamberlin, T. N., Dvir, A., Rabindran, S. K., Wu, C., and Dynan, W. S. (1995) Stimulation of the DNA-Dependent Protein Kinase by RNA Polymerase II Transcriptional Activator Proteins. J. Biol. Chem.. 270, 1449-1454.
88. Yumoto, Y., Shirakawa, H., Yoshida, M., Suwa, A., Watanabe, F., and Teraoka, H. (1998) High Mobility Group Proteins 1 and 2 can Function as DNA-Binding Regulatory Components for DNA-Dependent Protein Kinase in Vitro. J. Biochem.. 124, 519-527.
89. Watanabe, F., Shirakawa, H., Yoshida, M., Tsukada, K., and Teraoka, H. (1994) Stimulation of DNA-Dependent Protein Kinase Activity by High Mobility Group Proteins 1 and 2. Biochem. Biophys. Res. Commun.. 202, 736-742.
90. Dvir, A., Peterson, S. R., Knuth, M. W., Lu, H., and Dynan, W. S. (1992) Ku Autoantigen is the Regulatory Component of a Template-Associated Protein Kinase that Phosphorylates RNA Polymerase II. Proc. Natl. Acad. Sci. U. S. A.. 89, 11920-11924.
91. Dynan, W. S., and Yoo, S. (1998) Interaction of Ku Protein and DNA-Dependent Protein Kinase Catalytic Subunit with Nucleic Acids. Nucleic Acids Res.. 26, 1551-1559.
92. Gottlieb, T. M., and Jackson, S. P. (1993) The DNA-Dependent Protein Kinase: Requirement for DNA Ends and Association with Ku Antigen. Cell. 72, 131-142.
93. Myung, K., He, D. M., Lee, S. E., and Hendrickson, E. A. (1997) KARP-1: A Novel Leucine Zipper Protein Expressed from the Ku86 Autoantigen Locus is Implicated in the Control of DNA-Dependent Protein Kinase Activity. EMBO J.. 16, 3172-3184.
94. Lou, Z., Chen, B. P., Asaithamby, A., Minter-Dykhouse, K., Chen, D. J., and Chen, J. (2004) MDC1 Regulates DNA-PK Autophosphorylation in Response to DNA Damage. J. Biol. Chem.. 279, 46359-46362.
95. Yang, C. R., Leskov, K., Hosley-Eberlein, K., Criswell, T., Pink, J. J., Kinsella, T. J., and Boothman, D. A. (2000) Nuclear clusterin/XIP8, an x-Ray-Induced Ku70-Binding Protein that Signals Cell Death. Proc. Natl. Acad. Sci. U. S. A.. 97, 5907-5912.
96. Yang, C. R., Yeh, S., Leskov, K., Odegaard, E., Hsu, H. L., Chang, C., Kinsella, T. J., Chen, D. J., and Boothman, D. A. (1999) Isolation of Ku70-Binding Proteins (KUBs). Nucleic Acids Res.. 27, 2165-2174.
97. Morrison, C., Smith, G. C., Stingl, L., Jackson, S. P., Wagner, E. F., and Wang, Z. Q. (1997) Genetic Interaction between PARP and DNA-PK in V(D)J Recombination and Tumorigenesis. Nat. Genet.. 17, 479-482.
98. Ruscetti, T., Lehnert, B. E., Halbrook, J., Le Trong, H., Hoekstra, M. F., Chen, D. J., and Peterson, S. R. (1998) Stimulation of the DNA-Dependent Protein Kinase by Poly(ADP-Ribose) Polymerase. J. Biol. Chem.. 273, 14461-14467.
99. Ariumi, Y., Masutani, M., Copeland, T. D., Mimori, T., Sugimura, T., Shimotohno, K., Ueda, K., Hatanaka, M., and Noda, M. (1999) Suppression of the Poly(ADP-Ribose) Polymerase Activity by DNA-Dependent Protein Kinase in Vitro. Oncogene. 18, 4616-4625.
100. Bharti, A., Kraeft, S. K., Gounder, M., Pandey, P., Jin, S., Yuan, Z. M., Lees-Miller, S. P., Weichselbaum, R., Weaver, D., Chen, L. B., Kufe, D., and Kharbanda, S. (1998) Inactivation of DNA-Dependent Protein Kinase by Protein Kinase Cdelta: Implications for Apoptosis. Mol. Cell. Biol.. 18, 6719-6728.
101. Douglas, P., Moorhead, G. B., Ye, R., and Lees-Miller, S. P. (2001) Protein Phosphatases Regulate DNA-Dependent Protein Kinase Activity. J. Biol. Chem.. 276, 18992-18998.
102. Wechsler, T., Chen, B. P., Harper, R., Morotomi-Yano, K., Huang, B. C., Meek, K., Cleaver, J. E., Chen, D. J., and Wabl, M. (2004) DNA-PKcs Function Regulated Specifically by Protein Phosphatase 5. Proc. Natl. Acad. Sci. U. S. A.. 101, 1247-1252.
103. Leber, R., Wise, T. W., Mizuta, R., and Meek, K. (1998) The XRCC4 Gene Product is a Target for and Interacts with the DNA-Dependent Protein Kinase. J. Biol. Chem.. 273, 1794-1801.
104. Allen, C., Kurimasa, A., Brenneman, M. A., Chen, D. J., and Nickoloff, J. A. (2002) DNA-Dependent Protein Kinase Suppresses Double-Strand Break-Induced and Spontaneous Homologous Recombination. Proc. Natl. Acad. Sci. U. S. A.. 99, 3758-3763.
105. Allen, C., Halbrook, J., and Nickoloff, J. A. (2003) Interactive Competition between Homologous Recombination and Non-Homologous End Joining. Mol. Cancer. Res.. 1, 913-920.
106. Taccioli, G. E., Rathbun, G., Oltz, E., Stamato, T., Jeggo, P. A., and Alt, F. W. (1993) Impairment of V(D)J Recombination in Double-Strand Break Repair Mutants. Science. 260, 207-210.
107. Wright, W. E., Tesmer, V. M., Huffman, K. E., Levene, S. D., and Shay, J. W. (1997) Normal Human Chromosomes have Long G-Rich Telomeric Overhangs at One End. Genes Dev.. 11, 2801-2809.
108. Bailey, S. M., Cornforth, M. N., Ullrich, R. L., and Goodwin, E. H. (2004) Dysfunctional Mammalian Telomeres Join with DNA Double-Strand Breaks. DNA Repair (Amst). 3, 349-357.
109. Bailey, S. M., Brenneman, M. A., Halbrook, J., Nickoloff, J. A., Ullrich, R. L., and Goodwin, E. H. (2004) The Kinase Activity of DNA-PK is Required to Protect Mammalian Telomeres. DNA Repair (Amst). 3, 225-233.
110. Gilley, D., Tanaka, H., Hande, M. P., Kurimasa, A., Li, G. C., Oshimura, M., and Chen, D. J. (2001) DNA-PKcs is Critical for Telomere Capping. Proc. Natl. Acad. Sci. U. S. A.. 98, 15084-15088.
111. Goytisolo, F. A., Samper, E., Edmonson, S., Taccioli, G. E., and Blasco, M. A. (2001) The Absence of the Dna-Dependent Protein Kinase Catalytic Subunit in Mice Results in Anaphase Bridges and in Increased Telomeric Fusions with Normal Telomere Length and G-Strand Overhang. Mol. Cell. Biol.. 21, 3642-3651.
112. Kuhn, A., Gottlieb, T. M., Jackson, S. P., and Grummt, I. (1995) DNA-Dependent Protein Kinase: A Potent Inhibitor of Transcription by RNA Polymerase I. Genes Dev.. 9, 193-203.
113. Bannister, A. J., Gottlieb, T. M., Kouzarides, T., and Jackson, S. P. (1993) C-Jun is Phosphorylated by the DNA-Dependent Protein Kinase in Vitro; Definition of the Minimal Kinase Recognition Motif. Nucleic Acids Res.. 21, 1289-1295.
114. Britton, S., Froment, C., Frit, P., Monsarrat, B., Salles, B., and Calsou, P. (2009) Cell Nonhomologous End Joining Capacity Controls SAF-A Phosphorylation by DNA-PK in Response to DNA Double-Strand Breaks Inducers. Cell. Cycle. 8, 3717-3722.
115. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., and Anderson, C. W. (1992) Human DNA-Activated Protein Kinase Phosphorylates Serines 15 and 37 in the Amino-Terminal Transactivation Domain of Human p53. Mol. Cell. Biol.. 12, 5041-5049.
116. Komiyama, S., Taniguchi, S., Matsumoto, Y., Tsunoda, E., Ohto, T., Suzuki, Y., Yin, H. L., Tomita, M., Enomoto, A., Morita, A., Suzuki, T., Ohtomo, K., Hosoi, Y., and Suzuki, N. (2004) Potentiality of DNA-Dependent Protein Kinase to Phosphorylate Ser46 of Human p53. Biochem. Biophys. Res. Commun.. 323, 816-822.
117. Hill, R., Leidal, A. M., Madureira, P. A., Gillis, L. D., Waisman, D. M., Chiu, A., and Lee, P. W. (2008) Chromium-Mediated Apoptosis: Involvement of DNA-Dependent Protein Kinase (DNA-PK) and Differential Induction of p53 Target Genes. DNA Repair (Amst). 7, 1484-1499.
118. Wang, S., Guo, M., Ouyang, H., Li, X., Cordon-Cardo, C., Kurimasa, A., Chen, D. J., Fuks, Z., Ling, C. C., and Li, G. C. (2000) The Catalytic Subunit of DNA-Dependent Protein Kinase Selectively Regulates p53-Dependent Apoptosis but Not Cell-Cycle Arrest. Proc. Natl. Acad. Sci. U. S. A.. 97, 1584-1588.
119. Woo, R. A., Jack, M. T., Xu, Y., Burma, S., Chen, D. J., and Lee, P. W. (2002) DNA Damage-Induced Apoptosis Requires the DNA-Dependent Protein Kinase, and is Mediated by the Latent Population of p53. EMBO J.. 21, 3000-3008.
120. Kirchgessner, C. U., Patil, C. K., Evans, J. W., Cuomo, C. A., Fried, L. M., Carter, T., Oettinger, M. A., and Brown, J. M. (1995) DNA-Dependent Kinase (p350) as a Candidate Gene for the Murine SCID Defect. Science. 267, 1178-1183.
121. Wiler, R., Leber, R., Moore, B. B., VanDyk, L. F., Perryman, L. E., and Meek, K. (1995) Equine Severe Combined Immunodeficiency: A Defect in V(D)J Recombination and DNA-Dependent Protein Kinase Activity. Proc. Natl. Acad. Sci. U. S. A.. 92, 11485-11489.
122. Meek, K., Kienker, L., Dallas, C., Wang, W., Dark, M. J., Venta, P. J., Huie, M. L., Hirschhorn, R., and Bell, T. (2001) SCID in Jack Russell Terriers: A New Animal Model of DNA-PKcs Deficiency. J. Immunol.. 167, 2142-2150.
123. Perryman, L. E. (2004) Molecular Pathology of Severe Combined Immunodeficiency in Mice, Horses, and Dogs. Vet. Pathol.. 41, 95-100.
124. Fulop, G. M., and Phillips, R. A. (1990) The Scid Mutation in Mice Causes a General Defect in DNA Repair. Nature. 347, 479-482.
125. Lunn, D. P., McClure, J. T., Schobert, C. S., and Holmes, M. A. (1995) Abnormal Patterns of Equine Leucocyte Differentiation Antigen Expression in Severe Combined Immunodeficiency Foals Suggests the Phenotype of Normal Equine Natural Killer Cells. Immunology. 84, 495-499.
126. Danska, J. S., Holland, D. P., Mariathasan, S., Williams, K. M., and Guidos, C. J. (1996) Biochemical and Genetic Defects in the DNA-Dependent Protein Kinase in Murine Scid Lymphocytes. Mol. Cell. Biol.. 16, 5507-5517.
|Science Writers||Anne Murray|
|Illustrators||Victoria Webster, Katherine Timer|
|Authors||Carrie Arnold and Elaine Pirie|